Matt Ste Marie
About Matt Ste Marie
Matt Ste Marie is a Finance Manager at Boston Scientific, with extensive experience in financial analysis and strategic decision support across various departments.
Title
Matt Ste Marie is currently serving as the Finance Manager ICTx at Boston Scientific. He holds this role in Maple Grove, Minnesota, United States.
Current Roles at Boston Scientific
Matt Ste Marie is also the Principal Revenue & Markets Analyst for Coronary Therapies at Boston Scientific, located in Minneapolis, Minnesota, United States. He manages revenue and market analysis for stent, calcium, complex PCI, and drug-coated balloon products, providing strategic decision support across various departments including Marketing, R&D, Supply Chain, and Sales Ops.
Previous Roles at Boston Scientific
From 2016 to 2020, Matt Ste Marie served as Principal Financial Analyst for the Watchman product at Boston Scientific in the Greater Minneapolis-St. Paul Area.
Finance Analyst Roles at Target
Matt Ste Marie held several Senior Financial Analyst positions at Target in the Greater Minneapolis-St. Paul Area. These roles included Stores Expense Planning, Store Operations Finance, Capital Finance, and Risk Finance from 2010 to 2016.
Earlier Professional Experience
Prior to his roles at Boston Scientific and Target, Matt Ste Marie worked as a Financial Analyst in Corporate Real Estate at UnitedHealth Group from 2008 to 2010, and as a Financial Analyst Co-Op Intern at IBM Global Business Services from 2007 to 2008 in the Washington D.C. Metro Area.
Education and Expertise
Matt Ste Marie earned his Master of Business Administration (MBA) from the University of Minnesota, Carlson School of Management, from 2011 to 2014. He completed his undergraduate studies at St. Cloud State University with a B.S. in Finance from 2004 to 2008. Additionally, he attended Thomas Jefferson High School from 1999 to 2003.
Responsibilities at Boston Scientific
In his current role, Matt Ste Marie conducts investment case analysis for next-generation and cadency products within the Stent and cPCI families. He is responsible for hiring, leading, and developing direct reports, as well as assisting Business Development with market revenue projections and pro-forma P&Ls.